Literature DB >> 20826640

Detection and identification of Mycobacterium spp. in clinical specimens by combining the Roche Cobas Amplicor Mycobacterium tuberculosis assay with Mycobacterium genus detection and nucleic acid sequencing.

S Peter-Getzlaff1, J Lüthy, A Voit, G V Bloemberg, E C Böttger.   

Abstract

We have recently developed a PCR assay for detection of Mycobacterium spp. at the genus level based on the Cobas Amplicor platform. The sensitivities for smear-positive and smear-negative specimens were found to be 100% and 47.9%, respectively. The specificity was 97.7%, the positive predictive value 84.6%, and the negative predictive value 93.1%. In a follow-up study, we have systematically evaluated the Mycobacterium genus assay in parallel with the Cobas Amplicor Mycobacterium tuberculosis assay on 2,169 clinical specimens, including respiratory and nonrespiratory specimens. Based on the genus assay, nontuberculous mycobacteria were readily detected and identified to the species level by PCR-mediated sequencing. In addition, our data point to a limited specificity of the Cobas Amplicor M. tuberculosis assay.

Entities:  

Mesh:

Year:  2010        PMID: 20826640      PMCID: PMC3020847          DOI: 10.1128/JCM.00851-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

Review 1.  Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples.

Authors:  Claudio Piersimoni; Claudio Scarparo
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory.

Authors:  P P Bosshard; R Zbinden; S Abels; B Böddinghaus; M Altwegg; E C Böttger
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  Multicenter evaluation of two commercial amplification kits (Amplicor, Roche and LCx, Abbott) for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary specimens.

Authors:  E Tortoli; M Tronci; C P Tosi; C Galli; F Lavinia; S Natili; A Goglio
Journal:  Diagn Microbiol Infect Dis       Date:  1999-03       Impact factor: 2.803

4.  Mycobacterium frederiksbergense sp. nov., a novel polycyclic aromatic hydrocarbon-degrading Mycobacterium species.

Authors:  P Willumsen; U Karlson; E Stackebrandt; R M Kroppenstedt
Journal:  Int J Syst Evol Microbiol       Date:  2001-09       Impact factor: 2.747

5.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

Authors:  A Telenti; F Marchesi; M Balz; F Bally; E C Böttger; T Bodmer
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  Diagnosis of mycobacterial infections by nucleic acid amplification: 18-month prospective study.

Authors:  P Kirschner; J Rosenau; B Springer; K Teschner; K Feldmann; E C Böttger
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

7.  Detection of Mycobacterium tuberculosis by PCR amplification with pan-Mycobacterium primers and hybridization to an M. tuberculosis-specific probe.

Authors:  V J Tevere; P L Hewitt; A Dare; P Hocknell; A Keen; J P Spadoro; K K Young
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

8.  rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria.

Authors:  Toïdi Adékambi; Philippe Colson; Michel Drancourt
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 9.  Health impacts of environmental mycobacteria.

Authors:  Todd P Primm; Christie A Lucero; Joseph O Falkinham
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 10.  Clinical manifestations of nontuberculous mycobacteria infections.

Authors:  E Tortoli
Journal:  Clin Microbiol Infect       Date:  2009-10       Impact factor: 8.067

View more
  10 in total

1.  A case study of female genital tuberculosis in a Western European setting.

Authors:  C Kocher; R Weber; A Friedl
Journal:  Infection       Date:  2010-12-10       Impact factor: 3.553

2.  Evaluation of Cobas TaqMan MTB for direct detection of the Mycobacterium tuberculosis complex in comparison with Cobas Amplicor MTB.

Authors:  Guido V Bloemberg; Antje Voit; Claudia Ritter; Vanessa Deggim; Erik C Böttger
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

3.  Evaluation of the speed-oligo direct Mycobacterium tuberculosis assay for molecular detection of mycobacteria in clinical respiratory specimens.

Authors:  Ana Lara-Oya; Pablo Mendoza-Lopez; Javier Rodriguez-Granger; Ana María Fernández-Sánchez; María Pilar Bermúdez-Ruiz; Inmaculada Toro-Peinado; Begoña Palop-Borrás; Jose María Navarro-Marí; Miguel José Martínez-Lirola
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

4.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

5.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

Review 6.  An Update on Global Tuberculosis (TB).

Authors:  Balkis A Talip; Roy D Sleator; Colm J Lowery; James S G Dooley; William J Snelling
Journal:  Infect Dis (Auckl)       Date:  2013-05-21

7.  Comparative genomic analysis of Mycobacterium iranicum UM_TJL against representative mycobacterial species suggests its environmental origin.

Authors:  Joon Liang Tan; Yun Fong Ngeow; Wei Yee Wee; Guat Jah Wong; Hien Fuh Ng; Siew Woh Choo
Journal:  Sci Rep       Date:  2014-11-24       Impact factor: 4.379

8.  Diagnostic challenges of tuberculous lymphadenitis using polymerase chain reaction analysis: a case study.

Authors:  Hirokazu Taniguchi; Masahiko Nakamura; Kazuki Shimokawa; Fumi Kamiseki; Shin Ishizawa; Hitoshi Abo; Hideaki Furuse; Takeshi Tsuda; Yasuaki Masaki; Kensuke Suzuki
Journal:  Case Rep Infect Dis       Date:  2015-01-22

9.  Diagnostic Molecular Mycobacteriology in Regions With Low Tuberculosis Endemicity: Combining Real-time PCR Assays for Detection of Multiple Mycobacterial Pathogens With Line Probe Assays for Identification of Resistance Mutations.

Authors:  Vanessa Deggim-Messmer; Guido V Bloemberg; Claudia Ritter; Antje Voit; Rico Hömke; Peter M Keller; Erik C Böttger
Journal:  EBioMedicine       Date:  2016-06-14       Impact factor: 8.143

10.  Ulcers as a Sign of Skin Infection with Mycobacterium wolinskyi: Report of a Case and Review of the Literature.

Authors:  Simon Bossart; Barbara Schnell; Katrin Kerl; Mirjana Urosevic-Maiwald
Journal:  Case Rep Dermatol       Date:  2016-06-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.